Heron Therapeutics Stock News

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Heron Therapeutics

Two Sigma Investments LP cut its stake in shares of Heron Therapeutics Inc (NASDAQ:HRTX) by 13.3% in the first quarter, according to the company in its most recent filing with the Securities and Excha

Biotech stocks rebounded along with the broader market in the week ended June 19. The week was a busy one from the perspective of PDUFA dates, with the FDA issuing approvals for Merck & Co., Inc. (NYS

Biotech stocks rebounded along with the broader market in the week ended June 19. The week was a busy one from the perspective of PDUFA dates, with the FDA issuing approvals...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th

Heron Therapeutics and Novavax are two key healthcare stocks to watch this month.

BNP Paribas Arbitrage SA boosted its stake in Heron Therapeutics Inc (NASDAQ:HRTX) by 782.5% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchan

Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most importan

Despite the FDA tied up with COVID-19-related activities, May turned out to be a positive month for biopharma companies from the perspective of drug approvals. Three new molecular...

Despite COVID-19's devastating impact, one legendary stock picker might have just cracked the market code. While the broader market tumbled, investing firm Renaissance Technologies and its founder Jim

Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most importan